Summers v. Boehringer Ingelheim Pharmaceuticals Inc et al

Filing 3

CONDITIONAL TRANSFER ORDER (CTO-4) transferring case to the USDC for the Southern District of Illinois to be included with MDL No. 2385, IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION. Signed by Jeffery N. Luthi, Clerk of the Panel. (vjt)

Download PDF
FILED U.S. DISTRICT COURT EASTERN DISTHICT ARKANSAS UNITED STATES JUDICIAL PANEL AUG 2 9 2012 MULTIDISTRICT LITIGATION JAMES W. McCORM"'GKCLERK By: v_--r_ - on DEPCLERK IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION FfL~DNo.2385 AUG 2 9 20f2 (SEE ATTACHED SCHEDULE) ClERK US SOUTHERN DISTRICT COURT S~~t~RJ~Toc::;:lliNOIS 0 EAST 0 CONDITIONAL TRANSFER ORDER (CTO -4) ce On August 8, 2012, the Paneltransferred 13 civil action(s) to the United States District Court for the Southern District of Illinois for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. §1407. See _F.Supp.2d_ (J.P.M.L. 2012). Since that time, 17 additional action(s) have been transferred to the Southern District of Illinois. With the consent of that court, all such actions have been assigned to the Honorable David R Herndon. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Illinois and assigned to Judge Herndon. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Liti"ation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Southern District of Illinois for the reasons stated in the order of August 8, 2012, and, with the consent of that court, assigned to the Honorable David R Herndon. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Southern District of Illinois. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel. FOR THE PANEL: Inasmuch as no objection is pending at this time, the stay is lifted. ,~ Jeffery N. Liithi Clerk of the Panel Aug 29,2012 CLERK'S OFFICE UNITED STATES JUDICIAL PANEL ON MULTIDISTRICT LITIGATION SOUTHERN DISTRICT OF ILLINOIS By iT~~py Deputy Clerk Date Og fd.$Dif.r 1 IN RE: PRADAXA (DABIGATRAN ETEXILATE} PRODUCTS LIABILITY LITIGATION MDLNo.2385 SCHEDULE CT0-4- TAG-ALONG ACTIONS C.A.NO. CASE CAPTION ARKANSAS EASTERN ARE 4 12-00507 Summers v. Boehringer lngelheim Pharmaceuticals Inc et all1· t?b0?0 Dtutj)Cw ARKANSAS WESTERN ARW 2 12-02185 ARW 3 12-03108 ARW 4 12-04096 Dalton v. Boehringer, Ingelheim Pharmaceuticals, Inc. \1.·bl>O?io OlttfSCW et al Brooks v. Boehringer, Ingelheim Pharmaceuticals, Inc.ll·~00;1 ORH/SCW et al Langdon v. Boehringer, lngelheim Pharmaceuticals, ll·L!OO~& 0rtH ~CW Inc. et al I LOUISIANA WESTERN LAW 2 12-02125 Hay v. Boehringer Ingelheim Pharmaceuticals Inc et all"Z·bbO~CJ Ol~ISCw' TENNESSEE EASTERN TNE 3 12-00419 TNE 3 12-00420 Zydel v. Boehringer Ingelheim Pharmaceuticals, Inc. tZ.·IoCOl\() ~t\\lSCw et al Marino v. Boehringer Ingelheim Pharmaceuticals, Inc.\1·b00~\ O~H\SCW et al TENNESSEE WESTERN TNW 1 \l·loQOql 0~\\lStW 12-01177 Lunsford v. Boehringer Ingelheim Pharmaceuticals, Inc. et al . Kee v. Boehringer lngelheim Pharmaceuticals, Inc. et\1..·\oOO'HOvtHISCW al Runte v. Boehringer Ingelheim Pharmaceuticals, Inc.\1· b(X)~'1- ~R\\ SC vJ et al ~err v. Boehringer Ingelheim Pharmaceuticals, Inc. et n·~ooo"l'? Dtt\\~CvJ TEXAS EASTERN TXE 6 12-00497 TXE 6 12-00498 TXE 9 12-00125 I TEXAS NORTHERN TXN 2 12-00166 TXN 4 12-00555 TXN 4 12-00557 Jordan v. Boehringer Ingelheim Pharmaceuticals, Inc. \1·bOO~b O'-HjSCW et al Landers v. Boehringer Ingelheim Pharmaceuticals, \1.·b()b~l \)l.\\ISCW Inc. et al ~frry v. Boehringer Ingelheim Pharmaceuticals, Inc. et\1.:~004~ Cl2.\\(scvJ TXN 6 12-00053 ~tlfv. Boehringer Ingelheim Pharmaceuticals, Inc. etll·Wt¥\ Urt\-\l \Cw TEXAS SOUTHERN TXS 4 12-02381 TXS 4 12-02427 Cannon v. Boehringer Ingelheim Pharmaceuticals, Inc.n·~t> \)'tJ\\ScvJ et al ~a~ford v. Boehringer Ingelheim Pharmaceuticals, Inc.\l·\;l)()S\ \)~\\\Stw' TEXAS WESTERN TXW 1 12-00715 TXW 1 12-00716 Whitehouse v. Boehringer Ingelheim Pharmaceuticals, \1 iQ£111. O~"lSCvJ Inc. et al ~onti v. Boehringer Ingelheim Pharmaceuticals, Inc. et(l·bOOc?; D~\\ \srw

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?